Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells

References

• McWilliams MM, Chennathukuzhi VM. Recent advances in uterine fibroid etiology. Semin Reprod Med. 2017;35:181–189.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu Y, Zhu Y, et al. Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells. Cancer Cell Int. 2013;13:24.
   PubMed Web of Science ®Google Scholar
• Wang CZ, Xie JT, Fishbein A, et al. Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells. Phytother Res. 2009;23:6–13.
   PubMed Web of Science ®Google Scholar
• Palumbo R, Sampaolesi M, De Marchis F, et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol. 2004;164:441–449.
   PubMed Web of Science ®Google Scholar
• Kang R, Xie Y, Zhang Q, et al. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. Cell Res. 2017;27:916–932.
   PubMed Web of Science ®Google Scholar
• Zhou LY, Shi LY, Xiao Y. Changes of HMGB1 expression on angiogenesis of ovarian cancer and its mechanism. J Biol Regul Homeost Agents. 2016;30:233–238.
   PubMed Web of Science ®Google Scholar
• Luan X, Ma C, Wang P, et al. HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition. Onco Targets Ther. 2017;10:1389–1402.
   PubMed Web of Science ®Google Scholar
• Wu HL, Chuang TY, Al-Hendy A, et al. Berberine inhibits the proliferation of human uterine leiomyoma cells. Fertil Steril. 2015;103:1098–1106.
   PubMed Web of Science ®Google Scholar
• Otsuka H, Yoshida K, Kusano S, et al. Establishment of primary culture of cells derived from uterine leiomyoma. Nihon Sanka Fujinka Gakkai Zasshi. 1987;39:271–278.
   PubMedGoogle Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin. 2015; 65:87–108.
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289.
   PubMed Web of Science ®Google Scholar
• Sun M, Ye Y, Xiao L, et al. Anticancer effects of ginsenoside Rg3 (Review). Int J Mol Med. 2017;39:507–518.
   PubMed Web of Science ®Google Scholar
• Gao Y, Chu S, Zhang Z, et al. Hepataprotective effects of ginsenoside Rg1 – a review. J Ethnopharmacol. 2017;206:178–183.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang C, Jia Y, et al. Oxygen-carbon nanotubes as a chemotherapy sensitizer for Paclitaxel in breast cancer treatment. PLOS One. 2014;9:e104209.
   PubMed Web of Science ®Google Scholar
• Mujumdar N, Banerjee S, Chen Z, et al. Triptolide activates un-folded protein response leading to chronic ER stress in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol. 2014;306:G1011–G1020.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xu J, Li Z, et al. Ginsenoside Rh2 suppresses growth of uterine leiomyoma in vitro and in vivo and may regulate ERα/c-Src/p38 MAPK activity. J Funct Foods. 2015;18:73–82.
   Web of Science ®Google Scholar
• Stros M, Launholt D, Grasser KD. The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins. Cell Mol Life Sci. 2007; 64:2590–2606.
   PubMed Web of Science ®Google Scholar
• Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141:347–357.
   PubMed Web of Science ®Google Scholar
• Hennig Y, Wanschura S, Deichert U, et al. Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol Hum Reprod. 1996;2:277–283.
   PubMed Web of Science ®Google Scholar
• Williams AJ, Powell WL, Collins T, et al. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol. 1997;150:911–918.
   PubMed Web of Science ®Google Scholar
• Michael K, Annemarie W, Ulrike F. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(y) in uterine leiomyomas. Am J Pathol. 1999;155:1535.
   PubMed Web of Science ®Google Scholar
• Tallini G, vanni R, Manfioletti G, et al. HMGI-C and HMGI(y) immunoreativity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest. 2000;80:359.
   PubMed Web of Science ®Google Scholar